To Evaluate if Multiple Doses of Rifampicin Change the Blood Concentration of YM150 (Darexaban)

NCT01406002 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics of Darexaban and Metabolites
Healthy Subjects

Interventions

DRUG: darexaban
DRUG: Rifampicin

Sponsor

Astellas Pharma Inc